79 related articles for article (PubMed ID: 22119637)
1. Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein.
Mintzer S; Skidmore CT; Rankin SJ; Chervoneva I; Pequinot E; Capuzzi DM; Sperling MR
Epilepsy Res; 2012 Jan; 98(1):88-93. PubMed ID: 22119637
[TBL] [Abstract][Full Text] [Related]
2. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein.
Mintzer S; Skidmore CT; Abidin CJ; Morales MC; Chervoneva I; Capuzzi DM; Sperling MR
Ann Neurol; 2009 Apr; 65(4):448-56. PubMed ID: 19296463
[TBL] [Abstract][Full Text] [Related]
4. Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.
Mintzer S; Trinka E; Kraemer G; Chervoneva I; Werhahn KJ
Epilepsia; 2018 Oct; 59(10):1899-1907. PubMed ID: 30178473
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein.
Mintzer S; Miller R; Shah K; Chervoneva I; Nei M; Skidmore C; Sperling MR
Epilepsy Behav; 2016 May; 58():127-32. PubMed ID: 27074299
[TBL] [Abstract][Full Text] [Related]
6. B-vitamin deficiency in patients treated with antiepileptic drugs.
Mintzer S; Skidmore CT; Sperling MR
Epilepsy Behav; 2012 Jul; 24(3):341-4. PubMed ID: 22658435
[TBL] [Abstract][Full Text] [Related]
7. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Kim DW; Lee SY; Shon YM; Kim JH
Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
[TBL] [Abstract][Full Text] [Related]
8. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
9. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
13. Effects of switching pravastatin to cerivastatin on C-reactive protein, butyrylcholinesterase, and lipids.
Shinn AH; Carr-Lopez SM; Smith JW; Elledge EA; Smith TJ
Curr Med Res Opin; 2005 Feb; 21(2):207-14. PubMed ID: 15801991
[TBL] [Abstract][Full Text] [Related]
14. Topiramate: effects on serum lipids and lipoproteins levels in children.
Franzoni E; Verrotti A; Sarajlija J; Garone C; Matricardi S; Salerno GG; Monti M; Chiarelli F
Eur J Neurol; 2007 Dec; 14(12):1334-7. PubMed ID: 17916078
[TBL] [Abstract][Full Text] [Related]
15. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
16. [Influence of anti-epileptic drugs on blood lipid parameters: preliminary data].
Morgante L; Serra S; Musolino R; Gallitto G
Boll Soc Ital Biol Sper; 1981 Feb; 57(3):297-303. PubMed ID: 7236405
[TBL] [Abstract][Full Text] [Related]
17. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
19. Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial.
Elger CE; Rademacher M; Brandt C; Elmoufti S; Dedeken P; Eckhardt K; Tennigkeit F; De Backer M
Epilepsy Behav; 2016 Sep; 62():1-5. PubMed ID: 27423106
[TBL] [Abstract][Full Text] [Related]
20. Malnutrition, inflammation, and lipids in a cohort of dialysis patients.
Bowden RG; Wilson RL
Postgrad Med; 2010 May; 122(3):196-202. PubMed ID: 20463430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
